A 67-year-old female patient with no prior history of benign thyroid disease was diagnosed with primary thyroid lymphoma and was staged with 18 F-fluoro-2-deoxy-D-glucose ( 18 F-FDG) positron emission tomography/computed tomography (PET/ CT). She was treated with chemotherapy and external beam radiation therapy, and a follow-up PET/CT showed significant reduction in the size of the thyroid lymphoma with persistent intense 18 F-FDG uptake, which was interpreted as partial response to therapy. However, two subsequent PET/CT studies showed no change in the persistent intense 18 F-FDG uptake in the thyroid and a biopsy confirmed the presence of thyroiditis with no evidence of residual lymphoma. Follow-up PET/CTs performed over the subsequent three years showed stable intensely 18 F-FDG avid thyroiditis with no evidence of lymphoma recurrence. We present the imaging characteristics of a long term radiation treatment induced thyroiditis mimicking 18 F-FDG avid residual disease on PET/CT.
. A 67-year-old woman with no prior history of benign thyroid disease presented with a two month history of fevers, night sweats, and rapidly enlarging neck mass. Biopsy of the right thyroid lobe revealed a diffuse large B-cell lymphoma (DLBCL). A staging 18 F-fluoro-2-deoxy-D-glucose ( 18 F-FDG) positron emission tomography/computed tomography (PET/CT) (Discovery-ST, GE Healthcare, WI, USA) was performed and maximum intensity projection (MIP) images, (A) anterior and (B) left lateral, showed a large intensely 18 F-FDG avid mass in the right neck with no distant metastases. The patient was treated with 3 cycles of CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine, prednisone) followed by external beam radiation therapy. The first follow-up PET/CT was performed 3 months after the end of radiation therapy and MIP views, (A) anterior and (B) left lateral, show a dramatic reduction in the size of right thyroid DLBCL and resolution of tracheal compression with persistently intense 18 F-FDG uptake in both thyroid lobes with SUV max 8.9 on the right. These findings were interpreted as partial response to therapy, however since the patient was asymptomatic, a conservative management approach was taken. Figure 5 . A second follow-up PET/CT was performed one year later. SUV max of right thyroid lobe was 10.2, unchanged according to PET Response Criteria in Solid Tumors (PERCIST 1.0). The pattern of 18 F-FDG uptake and distribution in the thyroid gland were also unchanged. Biopsy of both thyroid lobes revealed thyroiditis with no evidence of residual lymphoma. A third follow-up PET/CT was performed 2 years later and SUV max in the right thyroid lobe was 9.5 (unchanged according to PERCIST) with stable pattern of 18 F-FDG uptake and distribution, consistent with remission. Primary thyroid lymphoma makes up 1-5% of thyroid malignancies and less than 2% of extranodal lymphomas (1) . It is more common in women, and patients present in the seventh decade of life with rapidly enlarging neck mass (1,2,3,4) . The use of 18 F-FDG PET/CT to stage primary thyroid lymphoma and evaluate response to therapy has been previously reported in the literature (5, 6) . Recent studies have raised concern about high rate of false positives on PET/ CT performed following therapy for thyroid lymphoma, although these have been attributed to Hashimoto's thyroiditis (7, 8, 9, 10, 11, 12) . External beam radiation therapy can produce both inflammatory and proliferative changes in the thyroid gland with increases in macrophage populations (9, 10) . Studies have shown that 18 F-FDG uptake is increased in head and neck soft tissues affected by such inflammatory and proliferative processes and lasts several months after the completion of radiation therapy (11, 12) . The present case is an example of a long-term post-treatment thyroiditis, which remained intensely 18 F-FDG avid but stable on several follow-up PET/CTs spanning three years, which to our knowledge has not been previously reported in the literature.
